Clinical Trials Browser

Rhabdomyosarcoma × Vascular Endothelial Growth Factor A × 90 days × Clear all

NCT01871766 2026-04-24

Risk-Adapted Focal Proton Beam Radiation and/or Surgery in Patients With Low, Intermediate and High Risk Rhabdomyosarcoma Receiving Standard or Intensified Chemotherapy

Phase 2 Active not recruiting

Rhabdomyosarcoma